is ghk cu a subcutaneous injection ghk-cu receptor agonist it safe to use (SC) GHK‑Cu (glycyl‑histidyl‑lysine copper peptide) injections for prolonged cycles in combination with ratatrutide (GLP‑1 agonist)? Peptide as a Natural – GHK-Cu: The Regenerative Peptide for

Its claim to fame in the research community is its pleiotropic effectsmeaning it appears to influence multiple biological pathways simultaneously

Once-weekly dosing is convenient

Elevated homocysteine levels are also a possible risk factor and vitamin B12 and folate supplementation lower homocysteine levels

History [edit] Descriptions of deficiency effects [edit] Between 1849 and 1887, Thomas Addison described a case of pernicious anemia, William Osler and William Gardner first described a case of neuropathy, Hayem described large red cells in the peripheral blood in this condition, which he called "giant blood corpuscles" (now called macrocytes), Paul Ehrlich identified megaloblasts in the bone marrow, and Ludwig Lichtheim described a case of myelopathy

PMID: 36601368